A case of severe ketoacidosis as the first clinical manifestation of type 2 diabetes mellitus in a youngster

Autores/as

  • Bruno Bombaci <span class="x193iq5w xeuugli x13faqbe x1vvkbs x1xmvt09 x1lliihq x1s928wv xhkezso x1gmr53x x1cpjm7i x1fgarty x1943h6x xudqn12 x3x7a5m x6prxxf xvq8zen xo1l8bm xzsf02u x1yc453h" dir="auto">Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina</span>
  • Fortunato Lombardo Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina<strong> </strong>
  • Stefano Passanisi Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina<strong> </strong>
  • Sara Aramnejad Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina<strong> </strong>
  • Rossella Morello Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina<strong> </strong>
  • Mariella Valenzise Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina<strong> </strong>
  • Giuseppina Salzano Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina
  • Malgorzata Gabriela Wasniewska Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina

DOI:

https://doi.org/10.13129/1828-6550/APMB.112.2.2024.CCS1

Palabras clave:

obesity, pediatrics, type 1 diabetes, type 2 diabetes

Resumen

Type 2 diabetes (T2D) is a chronic condition caused by insulin resistance and relative insulin deficiency, leading to disrupted glucose homeostasis. Several genetic, behavioral, and socio-economic factors have been recognized as predisposing factors. The incidence of T2D in the pediatric population is increasing, paralleling the rise in obesity rates among youths. Early diagnosis and initiation of therapy are crucial to preventing or delaying long-term complications. We present the case of a 13-year-old Caucasian boy who presented with respiratory distress and altered consciousness, preceded by fever, cough, polyuria, and polydipsia. Blood gas analysis revealed metabolic acidosis (pH 7.1, Na 129.4 mmol/l, K 3.81 mmol/l, HCO3- 3.4 mmol/l, BE -23.65 mmol/l), ketonemia (4.8 mmol/l), and hyperglycemia (541 mg/dl), consistent with diabetic ketoacidosis. Further investigations, prompted by persistent respiratory distress and increased inflammatory markers, led to the diagnosis of complicated pneumonia. Based on clinical signs of insulin resistance (such as acanthosis nigricans), obesity (BMI 25.6 kg/m2), family history of T2D (father), and after excluding type 1 diabetes, monogenic, and other forms of diabetes, a diagnosis of T2D was eventually established. Following resolution of diabetic ketoacidosis, therapy with metformin was started, with prompt achievement of satisfactory glucose control. This case underscores the possible association between infections, accelerated metabolic decompensation, and severe diabetic ketoacidosis in individuals predisposed to T2D.

Referencias

1. Shah, A.S., Zeitler, P.S., Wong, J., Pena, A.S., Wicklow, B., Arslanian, S., Chang, N., Fu, J., Dabadghao, P., Pinhas-Hamiel, O., Urakami, T., Craig, M.E. (2022). ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 diabetes in children and adolescents. Pediatr Diabetes, 23(7), 872-902. doi: 10.1111/pedi.13409

2. Perng, W., Conway, R., Mayer-Davis, E., Dabelea, D. (2023). Youth-Onset Type 2 Diabetes: The Epidemiology of an Awakening Epidemic. Diabetes Care, 46(3), 490-499. doi: 10.2337/dci22-0046

3. Glaser, N., Fritsch, M., Priyambada, L., Rewers, A., Cherubini, V., Estrada, S., Wolfsdorf, J.I., Codner, E. (2022). ISPAD clinical practice consensus guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes, 23(7), 835-856. doi: 10.1111/pedi.13406

4. Daryabor, G., Atashzar, M.R., Kabelitz, D., Meri, S., Kalantar, K. (2020). The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System. Front Immunol, 11, 1582. doi: 10.3389/fimmu.2020.01582

5. Shah, B.R., Hux, J.E. (2003). Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care, 26(2), 510-3. doi: 10.2337/diacare.26.2.510

6. Pinhas-Hamiel, O., Zeitler, P. (2007). Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet, 369(9575), 1823-1831. doi: 10.1016/S0140-6736(07)60821-6

Konstantinov, N.K., Rohrscheib, M., Agaba, E.I., Dorin, R.I., Murata, G.H., Tzamaloukas, A.H. (2015). Respiratory failure in diabetic ketoacidosis. World J Diabetes, 6(8), 1009-23. doi: 10.4239/wjd.v6.i8.1009

Descargas

Publicado

2025-01-10

Número

Sección

CLINICAL CASE SEMINAR